http://archive.fast-edgar.com/20261002/AT2ZF22GZC2RD2Z2222S2WYJMCNBZZ22D882
Filed on: October 2, 2026
The information in this preliminary pricing supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities and Exchange Commission. This preliminary pricing supplement and the accompanying product supplement, index supplement, prospectus supplement and prospectus are not an offer to sell these... (continue reading...)
Terms supplement to the prospectus dated April 17, 2026, the prospectus supplement dated April 17, 2026, the product supplement no. 3-I dated April 17, 2026, the underlying supplement no. 5-I dated April 17, 2026 Registration Statement Nos. 333-293684 and 333-293684-01 Dated October 2, 2026 Rule 424(b)(3) North America Structured Investments 5yrNC6m MQUSSVA Auto Callable Contingent... (continue reading...)
Tidal Trust I 234 W Florida St, Suite 700 Milwaukee, WI 53204
October 2, 2026
VIA EDGAR TRANSMISSION
U.S. Securities and Exchange Commission (the “Commission”) Division of Investment Management 100 F Street, N.E. Washington, DC 20549
Re:Tidal Trust I (the “Trust”) File Nos. 333-227298, 811-23377
To the Commission:
Pursuant to Rule 497(j) under the Securities Act of 1933, as amended, and the regulations thereunder, the Trust on... (continue reading...)
More SEC Filings
View Older Stories-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 20FR12B Kelly Partners Group
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 8-K INTEGRA LIFESCIENCES For: Oct 02
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 8-K Century Therapeutics, For: Oct 02
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form D/A PMF Central Florida IV
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form D/A Anabranch Offshore Fund,
-
Form D/A Anabranch Fund, LP
-
Form 10-Q TAYLOR DEVICES, INC. For: Aug 31
-
Form 4 T Stamp Inc For: Sep 30 Filed by: McClintock William
-
Form 6-K Baozun Inc. For: Oct 02
-
Form 8-K HYPERION DEFI, INC. For: Sep 28
-
Form 8-K Surrozen, Inc./DE For: Oct 02
-
Form 4 T Stamp Inc For: Sep 30 Filed by: Potts Charles Edward
-
Form 8-K Celcuity Inc. For: Oct 01
-
Form 8-K Bally's Corp For: Oct 01
-
Form 6-K AC Immune SA For: Oct 02
-
Form 6-K PHAOS TECHNOLOGY HOLDING For: Sep 30
-
Form 8-K Thunder Bridge Capital For: Oct 02
-
Form 8-K/A OpenWorld, Inc. For: Sep 29
-
Form 4 Compass Therapeutics, For: Oct 01 Filed by: Lerner Neil
-
Form 8-K CNS Pharmaceuticals, For: Sep 30
-
Form 4 PERMA FIX ENVIRONMENTAL For: Oct 01 Filed by: Wamp Zach Paul
-
Form 4 PERMA FIX ENVIRONMENTAL For: Oct 01 Filed by: Bostick Thomas
-
Form 4 PERMA FIX ENVIRONMENTAL For: Oct 01 Filed by: Grumski Joseph Timothy
-
Form 4 PERMA FIX ENVIRONMENTAL For: Oct 01 Filed by: Shelton Larry
-
Form 4 PERMA FIX ENVIRONMENTAL For: Oct 01 Filed by: REEDER JOE
-
Form 4 PERMA FIX ENVIRONMENTAL For: Oct 01 Filed by: Duggan Kerry C
-
Form 4 PERMA FIX ENVIRONMENTAL For: Oct 01 Filed by: ZWECKER MARK A
-
Form 4 Uxin Ltd For: Oct 01 Filed by: Dai Kun
-
Form 8-K EchoStar CORP For: Oct 01
-
Form SC 13E3/A Utz Brands, Inc. Filed by: Utz Brands, Inc.
-
Form 4 SCHMID Group N.V. For: Sep 30 Filed by: Rauch Helmut
-
Form 425 Columbus Acquisition Filed by: Columbus Acquisition Corp/Cayman Islands
-
Form 424B1 Chilwa Minerals Ltd
-
Form S-8 Bilibili Inc.
-
Form 8-K Columbus Acquisition For: Oct 01

